Nasal Bleeding Associated with Fluoxetine and Risperidone Interaction: A Case Report

Mowla, Arash; Dastgheib, Seyed Ali; Ebrahimi, Ardalan; Pani, Alessandra

doi:10.1055/s-0029-1220889

Cited by 8 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Bleeding is a rarely reported side effect of risperidone. Literature search revealed only four published reports of risperidone-related bleeding, including hemorrhagic cystitis, 1) nasal bleeding, 2 , 3) and gastrointestinal bleeding. 4) …”

Section: Introductionmentioning

confidence: 99%

Risperidone-induced Gingival Bleeding in a Pediatric Case: A Dose-dependent Side Effect

Hergüner

Özayhan²,

Erdur

2016

Clin Psychopharmacol Neurosci

View full text Add to dashboard Cite

There are several case reports on risperidone-related bleeding; however, to our knowledge, there is no report about gingival bleeding associated with risperidone in the literature. We presented a case who experienced gingival bleeding when risperidone dose was increased to 0.5 mg/day, and subsided after decreasing the dose to 0.25 mg/day, suggesting a dose-dependent side-effect. The bleeding side effect of risperidone might be caused by several mechanisms, including 5-hydroxytryptamine 2A receptor antagonism. Although bleeding associated with risperidone is rarely reported, clinicians should be aware of this side effect.

show abstract

Section: Introductionmentioning

confidence: 99%

Risperidone-induced Gingival Bleeding in a Pediatric Case: A Dose-dependent Side Effect

Hergüner

Özayhan²,

Erdur

2016

Clin Psychopharmacol Neurosci

View full text Add to dashboard Cite

show abstract

Current awareness: Pharmacoepidemiology and drug safety

2010

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 23 sections: 1 Reviews; 2 General; 3 Anti‐infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non‐steroidal Anti‐inflammatory Agents; 7 CNS Agents; 8 Anti‐neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator‐Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti‐inflammatory Agents ‐ Steroidal; 19 Teratogens/fetal exposure; 20 Antidiabetic Agents; 21 Contrast Agents; 22 Bone Conservation Agents; 23 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.

show abstract